Detalhe da pesquisa
1.
A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
J Virol
; 96(17): e0011822, 2022 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35972290
2.
Exponential increase in neutralizing and spike specific antibodies following vaccination of COVID-19 convalescent plasma donors.
Transfusion
; 61(7): 2099-2106, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33829513
3.
A T cell-based SARS-CoV-2 spike protein vaccine provides protection without antibodies.
JCI Insight
; 9(5)2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38456504
4.
RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge.
Transl Res
; 248: 11-21, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35489692
5.
The Development of a Novel Nanobody Therapeutic for SARS-CoV-2.
bioRxiv
; 2020 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33236012